J&J 2Q11 2Q Revenues: $16.6 billion (+8%) 2Q Earnings: $2.8 billion (-20%) YTD Revenues: $32.8 billion (+6%) YTD Earnings: $6.3 billion (-33%) Comments: A huge currency swing improved J&J’s results. U.S. pharma revenues were up 4% to $3.2 billion for the quarter, and 5% for YTD to $6.6 billion. International pharma sales were up 23% in 2Q to $3.0 billion, but more than half of that gain came from currency rates. For YTD, international pharma revenues were up 16%, with slightly...